false
Catalog
Engaging youth and their caregivers in medication ...
Recording
Recording
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In a recent presentation organized by the New England Region Opioid Response Network, discussions focused on engaging youth and caregivers in medication-assisted treatment for opioid use disorders. Led by Dr. Amy Ewell, a child and addiction psychiatrist, the session emphasized the significance of using medication to effectively treat opioid use disorders among youth. Dr. Ewell highlighted various medications approved for opioid use disorders, such as naltrexone, buprenorphine, and methadone, discussing their mechanisms of action and the importance of these treatments in reducing overdose risk.<br /><br />Dr. Ewell stressed the need for clear communication between healthcare providers, youth, and caregivers, explaining common misconceptions about these treatments. It was noted that building a supportive environment within families and ensuring adherence to medication are crucial for successful outcomes. The presentation also covered the importance of harm reduction practices and overdose prevention, advocating for the education of youth and caregivers on the risks of fentanyl-laced substances, the use of naloxone, and the significance of contacting emergency services during an overdose.<br /><br />The overarching message was the need for integrating medication into broader treatment plans while emphasizing flexibility to meet individual needs, ensuring youth receive comprehensive support for recovery.
Keywords
opioid use disorders
medication-assisted treatment
youth engagement
caregiver involvement
naltrexone
buprenorphine
methadone
harm reduction
overdose prevention
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.
Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
8-Hour DEA Training Inquiries, email
PCSS-MOUD
.
ORN
opioidresponsenetwork.org
×
Please select your language
1
English